NMNAT-1 Antibody

This product is produced by and distributed for Abnova, a company based in Taiwan.

The coenzyme NAD and its derivatives are involved in hundreds of metabolic redox reactions and are utilized in protein ADP-ribosylation, histone deacetylation, and in some Ca(2+) signaling pathways. NMNAT (EC 2.7.7.1) is a central enzyme in NAD biosynthesis, catalyzing the condensation of nicotinamide mononucleotide (NMN) or nicotinic acid mononucleotide (NaMN) with the AMP moiety of ATP to form NAD or NaAD (Zhang et al., 2003 [PubMed 12574164]).[supplied by OMIM]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Hamster.

We have publications tested in 1 application: WB.

Showing Publications 1 - 2 of 2.

Publications using H00064802-B01P	Applications	Species
Shaw D, Wang X, Brown L et al. Infection-derived lipids elicit an immune deficiency circuit in arthropods. Nature Communications. [PMID: 25790189]
Falk MJ, Zhang Q, Nakamaru-Ogiso E et al. NMNAT1 mutations cause Leber congenital amaurosis Nat Genet 2012-07-29 [PMID: 22842227] (WB, Hamster)	WB	Hamster

Images	Ratings	Applications	Species	Date	Details
Enlarge	4 reviewed by: Qi Zhang	IF		08/21/2012	View Summary Application Immunofluorescence

Array H00064802-B01P

• NMNAT-1 Antibodies
• NMNAT-1 Lysate
• NMNAT-1 Proteins
• NMNAT-1 Proteins and Enzyme